SKIN PE Ratio & Valuation, Is SKIN Overvalued

Historical Valuation

Beauty Health Co (SKIN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.38 is considered Undervalued compared with the five-year average of 43.43. The fair price of Beauty Health Co (SKIN) is between 50.81 to 51.48 according to relative valuation method. Compared to the current price of 0.91 USD , Beauty Health Co By Undervalued By 98.22%.

Relative Value

Fair Zone

50.81-51.48

Current Price：0.91

98.22%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Beauty Health Co (SKIN) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Beauty Health Co (SKIN) has a current Price-to-Book (P/B) ratio of 1.94. Compared to its 3-year average P/B ratio of 4.57, the current P/B ratio is approximately -57.58% higher. Relative to its 5-year average P/B ratio of 11.97, the current P/B ratio is about -83.80% higher. Beauty Health Co (SKIN) has a Forward Free Cash Flow (FCF) yield of approximately 30.68%. Compared to its 3-year average FCF yield of 5.46%, the current FCF yield is approximately 461.74% lower. Relative to its 5-year average FCF yield of 1.87%, the current FCF yield is about 1542.62% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for SKIN competitors is 91.25, providing a benchmark for relative valuation. Beauty Health Co Corp (SKIN.O) exhibits a P/S ratio of 0.37, which is -99.6% above the industry average. Given its robust revenue growth of -1.35%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of SKIN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of SKIN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is SKIN currently overvalued or undervalued?

What is Beauty Health Co (SKIN) fair value?

SKIN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Beauty Health Co (SKIN) is between 50.81 to 51.48 according to relative valuation method.

How does SKIN's valuation metrics compare to the industry average?

The average P/S ratio for SKIN's competitors is 91.25, providing a benchmark for relative valuation. Beauty Health Co Corp (SKIN) exhibits a P/S ratio of 0.37, which is -99.60% above the industry average. Given its robust revenue growth of -1.35%, this premium appears unsustainable.

What is the current P/B ratio for Beauty Health Co (SKIN) as of Apr 03 2026?

As of Apr 03 2026, Beauty Health Co (SKIN) has a P/B ratio of 1.94. This indicates that the market values SKIN at 1.94 times its book value.

What is the current FCF Yield for Beauty Health Co (SKIN) as of Apr 03 2026?

As of Apr 03 2026, Beauty Health Co (SKIN) has a FCF Yield of 30.68%. This means that for every dollar of Beauty Health Co's market capitalization, the company generates 30.68 cents in free cash flow.

What is the current Forward P/E ratio for Beauty Health Co (SKIN) as of Apr 03 2026?

As of Apr 03 2026, Beauty Health Co (SKIN) has a Forward P/E ratio of 25.51. This means the market is willing to pay $25.51 for every dollar of Beauty Health Co's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Beauty Health Co (SKIN) as of Apr 03 2026?

As of Apr 03 2026, Beauty Health Co (SKIN) has a Forward P/S ratio of 0.38. This means the market is valuing SKIN at $0.38 for every dollar of expected revenue over the next 12 months.

SKIN Valuation